About this trial
Chlordecone, an organochlorine pesticide used in the French Caribbean for several decades, is recognized as an endocrine disruptor. Accumulation in thyroid tissue may be modeled using several factors, including blood chlordecone levels, environmental exposure associated with place of residence, and dietary habits.
Eligibility criteria
Qualifiers
adult patients hospitalized at the Guadeloupe University Hospital for surgical treatment of thyroid pathology
person affiliated to or beneficiaries of a social security system
person with free, informed, and written consent signed by the participant and the investigator
Disqualifiers
patients subject to a judicial safeguard measure,
patient under 18 years old
patient without signed consent
current pregnancy at the time of inclusion
Trial design
Treatments tested in this trial
- Blood and thyroid tissue collection
Treatment groups
Sponsors and collaborators
Centre Hospitalier Universitaire de la Guadeloupe
Lead sponsor
Institut Pasteur de Guadeloupe
Collaborator